Ferguson Wellman Capital Management’s Zimmer Biomet ZBH Stock Holding History

Ferguson Wellman Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$237K	Sell	2,626 -155	-6%	-$14.2K	﹤0.01%	378
2025 Q4	$250K	Sell	2,781 -520	-16%	-$49.3K	﹤0.01%	324
2025 Q3	$325K	Hold	3,301	–	–	0.01%	298
2025 Q2	$301K	Hold	3,301	–	–	0.01%	292
2025 Q1	$374K	Sell	3,301 -700	-17%	-$74.9K	0.01%	274
2024 Q4	$423K	Hold	4,001	–	–	0.01%	260
2024 Q3	$432K	Hold	4,001	–	–	0.01%	265
2024 Q2	$434K	Sell	4,001 -50	-1%	-$5.89K	0.01%	262
2024 Q1	$535K	Buy	4,051 +20	+0.5%	+$2.5K	0.01%	249
2023 Q4	$491K	Sell	4,031 -125	-3%	-$13.9K	0.01%	254
2023 Q3	$466K	Sell	4,156 -60	-1%	-$7.62K	0.01%	250
2023 Q2	$614K	Sell	4,216 -272	-6%	-$37K	0.01%	236
2023 Q1	$580K	Hold	4,488	–	–	0.01%	235
2022 Q4	$572K	Buy	4,488 +28	+0.6%	+$3.25K	0.01%	239
2022 Q3	$466K	Hold	4,460	–	–	0.02%	222
2022 Q2	$469K	Sell	4,460 -9	-0.2%	-$1.07K	0.02%	228
2022 Q1	$572K	Sell	4,469 -331	-7%	-$39.9K	0.02%	228
2021 Q4	$592K	Buy	4,800 +611	+15%	+$80K	0.02%	227
2021 Q3	$595K	Sell	4,189 -52	-1%	-$7.65K	0.02%	227
2021 Q2	$662K	Sell	4,241 -3	-0.1%	-$486	0.02%	215
2021 Q1	$659K	Sell	4,244 -206	-5%	-$31.9K	0.02%	211
2020 Q4	$666K	Sell	4,450 -326	-7%	-$46K	0.02%	255
2020 Q3	$631K	Buy	4,776 +276	+6%	+$36.1K	0.02%	242
2020 Q2	$522K	Buy	4,500 +155	+4%	+$17.9K	0.02%	244
2020 Q1	$426K	Sell	4,345 -202	-4%	-$26.5K	0.02%	241
2019 Q4	$661K	Sell	4,547 -206	-4%	-$28.4K	0.02%	244
2019 Q3	$634K	Hold	4,753	–	–	0.02%	243
2019 Q2	$543K	Sell	4,753 -30	-0.6%	-$3.51K	0.02%	245
2019 Q1	$593K	Hold	4,783	–	–	0.02%	238
2018 Q4	$482K	Sell	4,783 -294	-6%	-$33.1K	0.02%	255
2018 Q3	$648K	Sell	5,077 -345	-6%	-$41K	0.02%	221
2018 Q2	$587K	Sell	5,422 -556	-9%	-$60.5K	0.02%	237
2018 Q1	$633K	Sell	5,978 -232	-4%	-$26.9K	0.02%	229
2017 Q4	$728K	Sell	6,210 -95,883	-94%	-$10.8M	0.03%	217
2017 Q3	$11.6M	Buy	102,093 +1,547	+2%	+$179K	0.42%	73
2017 Q2	$12.5M	Buy	100,546 +94,606	+1,593%	+$11.2M	0.47%	67
2017 Q1	$704K	Sell	5,940 -31	-0.5%	-$3.51K	0.03%	206
2016 Q4	$598K	Buy	5,971 +389	+7%	+$41.7K	0.02%	219
2016 Q3	$705K	Hold	5,582	–	–	0.03%	185
2016 Q2	$652K	Buy	5,582 +131	+2%	+$14.8K	0.03%	195
2016 Q1	$564K	Sell	5,451 -33	-0.6%	-$3.19K	0.02%	209
2015 Q4	$546K	Buy	5,484 +33	+0.6%	+$3.23K	0.02%	230
2015 Q3	$497K	Sell	5,451 -329	-6%	-$33K	0.02%	231
2015 Q2	$613K	Buy	5,780 +463	+9%	+$51.2K	0.03%	227
2015 Q1	$607K	Sell	5,317 -103	-2%	-$11.8K	0.03%	230
2014 Q4	$597K	Hold	5,420	–	–	0.02%	234
2014 Q3	$529K	Sell	5,420 -77	-1%	-$7.57K	0.02%	222
2014 Q2	$554K	Buy	5,497 +523	+11%	+$51K	0.02%	225
2014 Q1	$457K	Buy	4,974 +2	+0%	+$184	0.02%	229
2013 Q4	$450K	Hold	4,972	–	–	0.02%	227
2013 Q3	$396K	Sell	4,972 -77	-2%	-$6.06K	0.02%	232
2013 Q2	$367K	Buy	+5,049	New	+$378K	0.03%	144

Other funds holding ZBH

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ferguson Wellman Capital Management's ZBH Position: Q1 2026 in Review

Ferguson Wellman Capital Management reduced its Zimmer Biomet (ZBH) stake by 5.6% in Q1 2026, selling an estimated $14.2K and leaving 2,626 shares worth $237K. The position accounts for ﹤0.01% of the portfolio, ranked #378.

Ferguson Wellman Capital Management first reported a position in ZBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $12.5M in Q2 2017. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

Ferguson Wellman Capital Management held 2,626 shares of Zimmer Biomet worth $237K as of Q1 2026.
Ferguson Wellman Capital Management sold 155 Zimmer Biomet shares in Q1 2026, an estimated $14.2K.
Zimmer Biomet made up ﹤0.01% of Ferguson Wellman Capital Management's portfolio in Q1 2026, its #378 holding.
Ferguson Wellman Capital Management first reported a position in Zimmer Biomet in Q2 2013 and has held it in 52 quarters since.
Ferguson Wellman Capital Management's Zimmer Biomet position peaked at $12.5M in Q2 2017.
912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Ferguson Wellman Capital Management's 13F filing for Q1 2026, filed 1 May 2026.